Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Disease
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03708900 |
|
Recruitment Status : Unknown
Verified May 2022 by RECORDATI GROUP.
Recruitment status was: Recruiting
First Posted : October 17, 2018
Last Update Posted : May 6, 2022
|
Sponsor:
RECORDATI GROUP
Information provided by (Responsible Party):
RECORDATI GROUP
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | February 21, 2023 |
| Estimated Study Completion Date : | November 29, 2023 |